Scholar Rock · 3 hours ago
US Medical Director Neuromuscular
Cambridge, MA
Full-time
Hybrid
Senior Level
5+ years expScholar Rock is a biopharmaceutical company focused on developing life-changing therapies for serious diseases. The US Medical Director will provide expert medical leadership, contribute to the US medical strategy, and oversee various medical activities related to neuromuscular diseases, including spinal muscular atrophy.
BiopharmaBiotechnologyMedicalTherapeutics
Responsibilities
Strategic ownership of US Medical Plans – pre and post launch
Organize external expert advisory boards, support scientific symposia, develop medical congress engagement strategy
Act as medical lead for medical legal review committee (MLR)
Analize medical insights to inform cross-functional strategies and tactics
Collaborate with cross-functional field teams to identify data and educational gaps
Provide strategic input for the development of educational and messaging
Lead the digital medical education strategy and execution
Continuously raise the bar for our externally facing materials, ensuring alignment to strategy
Oversee Medical activities related to review of promotional and scientific materials
Collaborate with functional groups as subject matter expert including Patient Advocacy, Commercial Operations, New Products, and many other internal stakeholders in support of pipeline products
Provide medical leadership to guide internal and external decision-making
Establish and maintain strong knowledge in SMA to optimize clinical study protocols development and execution
Establish and maintain strong relationships with experts in the field, academics and professionals
Ensure a patient-centric approach to development of clinical studies under her/his supervision
Collaborate cross functionally to execute the clinical studies under her/his responsibility in alignment with the Brand plan and Global Medical Plan
Collaborate with Global Medical to identify and execute internally and externally sponsored studies
Foster strong relationships with internal and external stakeholders to identify unique opportunities to improve and evolve educational and training content
Manage budget for assigned projects
Travel required, comprising approximately 20%
Qualification
Required
MD, PharmD, PhD or equivalent scientific degree. MBA desirable
Minimum 5 years' experience in industry R&D or Medical
Excellent written and communication skills, highly organized and able to manage supporting multiple initiatives
Preferred
Scientific communication and presentation skills with the ability to present scientific data in a credible manner. Able to interface professionally with a wide spectrum of internal and external academicians, in the scientific/medical arena
Leadership skills; personal style that includes a sense of urgency, as well as flexibility and ability to respond to rapidly changing environments and circumstances
Collaborative and proactive, with a hands-on, roll-up-the sleeves style and attitude
Highest integrity; committed to ethics and scientific standards
Solid track record of achievement in Medical Affairs in the biotech/pharma industry
Ideally have worked in the field of rare diseases; SMA experience would be advantageous
Launch experience is critical for this role
Field experience is helpful
Experience in clinical trial design, especially phase IIIb-IV
Demonstrated successful partnership with Commercial organization, developed KOL programs and relationships, offered field training, patient outreach programs and the like
A curious learner who is focused on patient outcomes and values collaboration and advancing scientific understanding
Be a critical thinker, able to share fact-based opinions without ego
Able to make complex science understandable for a non-scientific audience
Results-oriented, can embrace a fast-paced 'can do' culture
Have scope for personal growth and development
Company
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$743MKey Investors
InvusFidelityARCH Venture Partners
2024-10-08Post Ipo Equity· $300M
2023-10-11Post Ipo Equity· $85M
2022-06-17Post Ipo Equity· $205M
Leadership Team
Jay Backstrom
Chief Executive Officer
Recent News
Business Wire
2026-01-12
Morningstar.com
2025-12-13
Company data provided by crunchbase